Organovo Appoints Norman Staskey As CFO
Organovo Holdings, Inc. (ONVO), a clinical-stage biotech firm focused on advancing innovative treatments for inflammatory bowel ...
Organovo Announces Appointment of Norman Staskey as Chief Financial Officer
Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today ...
Organovo Holdings Appoints Norman Staskey as New CFO
Organovo Holdings ( (ONVO) ) has issued an announcement.
Organovo, Inc.: Organovo Announces Appointment of Norman Staskey as Chief Financial Officer
Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease ...
Nasdaq8d
Organovo Holdings Appoints Norman Staskey as New CFO
Organovo Holdings, Inc. appointed Norman Staskey as the new President, Chief Financial Officer, and Principal Financial Officer following the resignation of Tomas Hess, who left to pursue retirement.
Investing8d
Organovo appoints new president and CFO amid strategic plans
Organovo Holdings, Inc. (NASDAQ:ONVO), a biotechnology firm specializing in biological products with a current market capitalization of $5.5 million, announced the appointment of Norman Staskey as its ...
Investing8d
Organovo appoints new president and CFO amid strategic plans
Organovo Holdings, Inc. (NASDAQ:ONVO), a biotechnology firm specializing in biological products with a current market capitalization of $5.5 million, announced the appointment of Norman Staskey as ...